BioSpace News Archive

physIQ, Inc. and the US Department of Veteran’s Affairs have advanced their collaboration to address heart failure care to an interventional trial phase.

Additions include includes Steven Cramer, M.D., Seth Finklestein, M.D., Teresa Kimberley, Ph.D., P.T., Daniel Laskowitz, M.D, MHS, David Lin, M.D., and Gary Steinberg, M.D.

Synaptogenix, Inc. (OTC: SNPX) (the “Company”), an emerging biopharmaceutical company focused on developing therapies for neurodegenerative diseases, announced that it has submitted a formal application to list its common shares on the Nasdaq Stock Market (“Nasdaq”).

Taiga Biotechnologies, a cell-based immunotherapy company, announced today that a colorectal cancer patient at the Davidoff Cancer Center, Beilenson Hospital, Rabin Medical Center, Petach Tikva, was the first recipient of a treatment designed to treat drug-resistant solid tumors in the company’s recently approved Israeli trial. (NCT04640246).

Fibralign Corp., a Stanford spin-out and developer of therapeutic biomedical devices, today announced enrollment of the first patient in a multi-site, randomized clinical trial in Europe evaluating its BioBridge® Collagen Matrix as a novel preventative treatment for secondary lymphedema.

BostonGene Corporation, a biomedical software company committed to defining optimal precision medicine-based therapies for cancer patients, and Weill Cornell Medicine, today announced a publication in Cancer Discovery, a journal of the American Association for Cancer Research

MediXall Group, Inc., a healthcare technology company, announced it has launched Health Karma for Employers, a health services platform that provides millions of businesses with the ability to offer affordable, high-quality healthcare benefits to their employees, whether they are eligible for health insurance coverage or not.

Nationally-Recognized Research and the Imperative for Health Systems to Free Beds and Improve Outcomes More Quickly Fuel Insulin Dosing Technology Company’s Growth

ZebiAI, Inc., a biotech company focused on improving human health by powering machine learning (ML) to source novel targets and discover new therapeutics, today announced the appointment of Brian Goldman, Ph.D., as SVP and Chief Computation Officer.

PatientsLikeMe, the world’s largest integrated community, health management, and real-world data platform, today announced it has raised $26 million in financing led by Alta Partners, Hambrecht Ducera Growth Ventures, Optum Ventures and PBM Capital, with participation from Jeff Leerink and Symphony Ventures, an investment partnership established by Rory McIlroy and his team.